Skip to main content

Advertisement

Table 3 A summary of the meta-analysis for the markedly effective rate

From: Comparative efficacy of Chinese herbal injections for treating acute cerebral infarction: a network meta-analysis of randomized controlled trials

AADN 0.61(0.45,0.84) P = 0.96 i2 = 0%   0.75(0.48,1.16) P = 0.97 l2 = 0% 0.72(0.42,1.23) P = 0.82 I2 = 0% 0.56(0.26,1.17) 0.74(0.54,1.01) P = 0.91 I2 = 0% 0.67(0.40,1.14) P = 0.92 I2 = 0% 0.90(0.61,1.32) P = 0.71 I2 = 0% 0.93(0.46, 1.90) 0.72(0.33, 1.59) 0.81(0.54, 1.21) P = 0.79 I2 = 0% 0.61(0.30,1.26) 0.57(0.44,0.73) P = 0.19 I2 = 35.4%
3.89 (2.26, 6.26) DH 1.53 (0.84,2.80) 1.73 (0.89, 3.34) 1.22 (0.69,2.16)
0.8 (0.29, 1.8) 0.22 (0.07,0.52) DS 0.79 (0.53,1.19) 0.75 (0.41, 1.36) 0.64 (0.28,1.47)
2.14 (1.02, 3.99) 0.59 (0.23,1.23) 3.3 (0.91,8.58) DSCXQ 1.70 (0.81,3.59)
2.22 (0.95, 4.47) 0.61 (0.22,1.35) 3.38 (0.92,8.96) 1.16 (0.37,2.82) DZHS 0.70 (0.32,1.48) 0.75 (0.33,1.72)  
5.36 (1.06,16.68) 1.47 (0.26,4.87) 8.32 (1.12,30.55) 2.82 (0.44,9.73) 2.82 (0.42,9.88) DZXX
0.94 (0.57, 1.46) 0.25 (0.13,0.44) 1.41 (0.51,3.11) 0.49 (0.21,0.96) 0.48 (0.19,1.01) 0.29 (0.05,0.93) FFDS 0.61(0.38, 0.98) P = 0.89 I2 = 0% 0.74(0.51,1.07)P = 0.86 I2 = 0% 0.76(0.33, 1.76) 0.54(0.34,0.86)P = 0.70 I2 = 0% 0.75(0.53,1.06)P = 0.98 I2 = 0% 0.81(0.50,1.31)P = 0.65 I2 = 0%
3.34 (1.66, 6.14) 0.91 (0.37,1.91) 5.14 (1.48,13.28) 1.75 (0.62,4) 1.75 (0.56,4.22) 1.02 (0.16,3.51) 3.76 (1.61,7.65) HHHSS 1.85 (0.79, 4.29)
2.9 (1.36, 5.46) 0.79 (0.32,1.65) 4.43 (1.29,11.37) 1.52 (0.53,3.47) 1.51 (0.49,3.6) 0.89 (0.14,3.03) 3.18 (1.56,5.83) 0.97 (0.34,2.21) SX
3.27 (1.86, 5.35) 0.89 (0.42,1.66) 4.96 (1.68,11.54) 1.71 (0.68,3.58) 1.68 (0.67,3.51) 1 (0.17,3.27) 3.6 (2.03,5.97) 1.09 (0.44,2.23) 1.25 (0.52,2.55) SXT 1.38(0.86, 2.22) P = 0.86 I2 = 0% 1.47 (0.79, 2.78)
1.27 (0.53, 2.6) 0.34 (0.13,0.76) 1.78 (0.7,3.81) 0.66 (0.21,1.62) 0.66 (0.2,1.63) 0.39 (0.06,1.38) 1.39 (0.59,2.84) 0.42 (0.14,1) 0.49 (0.16,1.16) 0.41 (0.16,0.87) XST1 0.65 (0.37, 1.15)
2.24 (1.23, 3.77) 0.61 (0.29,1.12) 3.31 (1.25,7.23) 1.17 (0.46,2.51) 1.16 (0.43,2.56) 0.68 (0.12,2.28) 2.47 (1.36,4.14) 0.74 (0.31,1.5) 0.86 (0.35,1.77) 0.71 (0.38,1.25) 1.99 (0.85,3.94) XST2
1.64 (0.78, 3.09) 0.45 (0.18,0.96) 2.54 (0.7,6.6) 0.86 (0.29,2.01) 0.86 (0.27,2.06) 0.5 (0.08,1.73) 1.85 (0.76,3.8) 0.55 (0.19,1.25) 0.64 (0.22,1.48) 0.53 (0.22,1.07) 1.52 (0.47,3.66) 0.79 (0.31,1.68) LI
2.99 (1.53, 5.34) 0.81 (0.36,1.6) 4.43 (1.57,10.1) 1.56 (0.59,3.4) 1.52 (0.59,3.24) 0.91 (0.15,3.1) 3.24 (1.85,5.34) 1 (0.37,2.17) 1.14 (0.46,2.36) 0.96 (0.45,1.82) 2.69 (1.01,5.84) 1.41 (0.65,2.69) 2.05 (0.74,4.58) YXDM 1.32 (0.67,2.61)
3.3 (2, 5.14) 0.9 (0.46,1.59) 5.09 (1.64,12.18) 1.73 (0.71,3.61) 1.73 (0.64,3.79) 1.01 (0.18,3.3) 3.69 (1.97,6.31) 1.1 (0.45,2.25) 1.28 (0.53,2.61) 1.08 (0.52,1.98) 3.04 (1.12,6.65) 1.59 (0.75,2.97) 2.27 (0.91,4.75) 1.21 (0.54,2.33) SXN
1.33 (0.2, 4.65) 0.36 (0.05,1.3) 1.98 (0.24,7.46) 0.69 (0.09,2.61) 0.68 (0.09,2.47) 0.41 (0.03,1.84) 1.45 (0.23,4.95) 0.44 (0.06,1.65) 0.51 (0.07,1.86) 0.43 (0.06,1.52) 1.2 (0.15,4.48) 0.63 (0.09,2.24) 0.91 (0.11,3.45) 0.45 (0.08,1.44) 0.42 (0.06,1.51) MLN
  1. The upper right corner is the Meta-analysis results. The bottom left corner is the network Meta-analysis results. Results are the odds ratios (OR) and related 95% credibility interval (95% CI) in the row-defining treatment compared with the column -defining treatment. OR higher than 1 favor the row-defining treatment, and vice versa. Significant effects are printed in bold. AADN aspirin + anticoagulants + dehydrant + neuroprotectant, DH Danhong injection + AADN, DS Danshen injection + AADN, DSCXQ Danshenchuangxiongqin injection + AADN, DZHS Dengzhanhuasu injection + AADN, DZXX Dengzhanxixin injection + AADN, FFDS Fufangdanshen injection + AADN, HHHSS Honghuahuangsesu injection + AADN, SX Shenxiong glucose injection + AADN, SXT Shuxuetong injection + AADN, XST1 Xueshuantong injection + AADN, XST2 Xuesetong injection + AADN, LI Ligustrazine injection + AADN, YXDM Yinxingdamo injection + AADN, SXN Shuxuening injection + AADN, MLN Mailuoning injection + AAD